Table 1. Clinical characteristics of MS patients.
| Patient # | Patient ID | Sex | CSF IgG (μg/mL) | % IgG | OCBs | Diagnosis |
|---|---|---|---|---|---|---|
| MS #1 | MS 02–19 | F | 68 | 15.00 | 6 | PPMS |
| MS #2 | MS 02–21 | F | 65 | 16.00 | 3 | RRMS |
| MS #3 | MS 02–24 | F | 161 | 16.90 | 1 | SPMS |
| MS #4 | MS 03–01 | F | 70 | 23.00 | 6 | RRMS |
| MS #5 | MS 03–07 | F | 86 | 32.00 | 3 | RRMS |
| MS #6 | MS 04–02 | F | 219 | 21.00 | 5 | PPMS |
| MS #7 | MS 04–03 | M | 92 | 17.60 | 2 | RRMS |
| MS #8 | MS 04–05 | F | 46 | 16.40 | + | RRMS |
| MS #9 | MS 04–07 | F | 31 | 14.10 | + | PPMS |
| MS #10 | MS 05–01 | M | 92 | 23.00 | + | RRMS |
| MS #11 | MS 05–02 | F | 72 | 24.80 | 19 | RRMS |
| MS #12 | MS 05–03 | F | 57 | 23.70 | 21 | RRMS |
| MS #13 | MS 05–04 | F | 68 | 17.40 | 22 | SPMS |
| MS #14 | MS 05–06 | M | 28 | 8.00 | 14 | PPMS |
| MS #15 | MS 05–07 | M | 98 | 18.40 | 8 | RRMS |
| MS #16 | MS 05–08 | F | 112 | 22.40 | 19 | RRMS |
| MS #17 | MS 05–10 | F | 88 | 20.90 | 28 | RRMS |
| MS #18 | MS 06–02 | F | 12 | 5.50 | 12 | RRMS |
| MS #19 | MS 06–03 | F | 32 | 9.40 | 13 | RRMS |
| MS #20 | MS 06–06 | F | 127 | 33.40 | 19 | RRMS |
All MS patients whose CSF were used for panning phage-displayed random peptide libraries are included. Major immunological features such as CSF IgG concentration, percent of IgG in the CSF, number of oligoclonal bands and diagnosis are listed. The %IgG is the percent of total protein in CSF that corresponds to IgG. RRMS: relapsing remitting multiple sclerosis; SPMS: secondary progressive multiple sclerosis; PPMS: primary progressive multiple sclerosis.